A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN
The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JUNG, KWANG DON JI, HYUN KU KIM, IN SU |
| description | The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.
본 발명은 실로도신 또는 이의 약학적으로 허용가능한 염이 이산화규소에 흡착되어 형성된 고체 분산체를 포함하는 약제학적 제제 및 이의 제조방법에 관한 것으로, 실로도신의 용출 특성이 향상되는 효과가 있다. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR101578627BB1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR101578627BB1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR101578627BB13</originalsourceid><addsrcrecordid>eNrjZHB1VAj29wl18vTxDInUdfXzcPRzdnVRCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PdTcPb3DQjyDPb0c1cI9vTxd_EHMnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbx3kKGBoam5hZmRuZOToTFxqgBsYi2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN</title><source>esp@cenet</source><creator>JUNG, KWANG DON ; JI, HYUN KU ; KIM, IN SU</creator><creatorcontrib>JUNG, KWANG DON ; JI, HYUN KU ; KIM, IN SU</creatorcontrib><description>The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.
본 발명은 실로도신 또는 이의 약학적으로 허용가능한 염이 이산화규소에 흡착되어 형성된 고체 분산체를 포함하는 약제학적 제제 및 이의 제조방법에 관한 것으로, 실로도신의 용출 특성이 향상되는 효과가 있다.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151218&DB=EPODOC&CC=KR&NR=101578627B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151218&DB=EPODOC&CC=KR&NR=101578627B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JUNG, KWANG DON</creatorcontrib><creatorcontrib>JI, HYUN KU</creatorcontrib><creatorcontrib>KIM, IN SU</creatorcontrib><title>A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN</title><description>The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.
본 발명은 실로도신 또는 이의 약학적으로 허용가능한 염이 이산화규소에 흡착되어 형성된 고체 분산체를 포함하는 약제학적 제제 및 이의 제조방법에 관한 것으로, 실로도신의 용출 특성이 향상되는 효과가 있다.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB1VAj29wl18vTxDInUdfXzcPRzdnVRCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PdTcPb3DQjyDPb0c1cI9vTxd_EHMnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbx3kKGBoam5hZmRuZOToTFxqgBsYi2Q</recordid><startdate>20151218</startdate><enddate>20151218</enddate><creator>JUNG, KWANG DON</creator><creator>JI, HYUN KU</creator><creator>KIM, IN SU</creator><scope>EVB</scope></search><sort><creationdate>20151218</creationdate><title>A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN</title><author>JUNG, KWANG DON ; JI, HYUN KU ; KIM, IN SU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR101578627BB13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JUNG, KWANG DON</creatorcontrib><creatorcontrib>JI, HYUN KU</creatorcontrib><creatorcontrib>KIM, IN SU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JUNG, KWANG DON</au><au>JI, HYUN KU</au><au>KIM, IN SU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN</title><date>2015-12-18</date><risdate>2015</risdate><abstract>The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.
본 발명은 실로도신 또는 이의 약학적으로 허용가능한 염이 이산화규소에 흡착되어 형성된 고체 분산체를 포함하는 약제학적 제제 및 이의 제조방법에 관한 것으로, 실로도신의 용출 특성이 향상되는 효과가 있다.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR101578627BB1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T18%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JUNG,%20KWANG%20DON&rft.date=2015-12-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR101578627BB1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |